Scientific American’s round-up and run-down of what’s up with Ivermectin. Despite what fringe physicians’ groups recommend — “twice a week for as long as [COVID] risk is elevated” — ivermectin is usually given as a one-time dose when it is used as a parasite treatment for humans. Cases of severe poisoning and even death are on the rise. At the same time, clinical trials of Ivermectin as well as Fluvoxamine (serotonin uptake inhibitor), Metformin (glucose/insulin regulator), and Fluticasone (steroid) continue as researchers explore the possibility that drugs “known to decrease inflammatory proteins (cytokines) in the body” will treat covid.
COVID-OUT trial at University of Minnesota: If we give metformin, ivermectin, fluvoxamine, or a combination of these medications to individuals soon after they develop COVID-19, will it decrease the severity of their symptoms? Will it prevent them from needing hospitalization? This study hopes to answer these questions.